piroxicam Search Results


ir spectra  (Thermo Fisher)
93
Thermo Fisher ir spectra
Ir Spectra, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/piroxicam/Piroxicam/10__4314_slash_star__v3i1__8-52-0-16
Average 93 stars, based on 1 article reviews
ir spectra - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
piroxicam s1713  (Selleck Chemicals)
93
Selleck Chemicals piroxicam s1713
Piroxicam S1713, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/piroxicam/Piroxicam/pm37120570-111-3-7
Average 93 stars, based on 1 article reviews
piroxicam s1713 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
piroxicam  (Santa Cruz Biotechnology)
92
Santa Cruz Biotechnology piroxicam
Ibuprofen suppresses EFHD2 and sensitizes lung cancer cells to cisplatin. A) NSAIDs, aspirin 500 μM, diclofenac 40 μM, ibuprofen 600 μM, ketorolac 10 μM, mefenamic acid 2 μM, <t>piroxicam</t> 10 μM, and sulindac 20 μM, were used to treat both H1299 and F4 cells for 24 h. EFHD2 levels were determined by Western blot assay. B) H1299 and F4 cells were treated with indicated dose of ibuprofen. The relative EFHD2 levels in each sample were normalized to the control cell. β-actin, loading control. C) After 24 h pretreatment with indicated doses of ibuprofen, migration ability of H1299 and F4 cells was analyzed by real time quantification using the IncuCyte system. D) After 24 h pretreatment with indicated doses of ibuprofen, invasion ability of H1299 and F4 cells was analyzed by matrigel transwell system. Invaded cell number was normalized with cell viability and the relative invasion was normalized with the control cells. E) EFHD2-KD and the control H1299 cells and F) EFHD2-OE and the control A549 cells were pretreated with or without 600 μM ibuprofen for 24 h, and then indicated doses of cisplatin were added into culture media for another 24 h. Cell viability were determined by MTT assay. ★★ , <0.01.
Piroxicam, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/piroxicam/Piroxicam/pmc07243194-56-24-38
Average 92 stars, based on 1 article reviews
piroxicam - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
piroxicam standards  (LKT Laboratories)
86
LKT Laboratories piroxicam standards
Ibuprofen suppresses EFHD2 and sensitizes lung cancer cells to cisplatin. A) NSAIDs, aspirin 500 μM, diclofenac 40 μM, ibuprofen 600 μM, ketorolac 10 μM, mefenamic acid 2 μM, <t>piroxicam</t> 10 μM, and sulindac 20 μM, were used to treat both H1299 and F4 cells for 24 h. EFHD2 levels were determined by Western blot assay. B) H1299 and F4 cells were treated with indicated dose of ibuprofen. The relative EFHD2 levels in each sample were normalized to the control cell. β-actin, loading control. C) After 24 h pretreatment with indicated doses of ibuprofen, migration ability of H1299 and F4 cells was analyzed by real time quantification using the IncuCyte system. D) After 24 h pretreatment with indicated doses of ibuprofen, invasion ability of H1299 and F4 cells was analyzed by matrigel transwell system. Invaded cell number was normalized with cell viability and the relative invasion was normalized with the control cells. E) EFHD2-KD and the control H1299 cells and F) EFHD2-OE and the control A549 cells were pretreated with or without 600 μM ibuprofen for 24 h, and then indicated doses of cisplatin were added into culture media for another 24 h. Cell viability were determined by MTT assay. ★★ , <0.01.
Piroxicam Standards, supplied by LKT Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/piroxicam/Piroxicam/pmc07166601-43-2-7
Average 86 stars, based on 1 article reviews
piroxicam standards - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
piroxicam  (Taito corporation)
90
Taito corporation piroxicam
Ibuprofen suppresses EFHD2 and sensitizes lung cancer cells to cisplatin. A) NSAIDs, aspirin 500 μM, diclofenac 40 μM, ibuprofen 600 μM, ketorolac 10 μM, mefenamic acid 2 μM, <t>piroxicam</t> 10 μM, and sulindac 20 μM, were used to treat both H1299 and F4 cells for 24 h. EFHD2 levels were determined by Western blot assay. B) H1299 and F4 cells were treated with indicated dose of ibuprofen. The relative EFHD2 levels in each sample were normalized to the control cell. β-actin, loading control. C) After 24 h pretreatment with indicated doses of ibuprofen, migration ability of H1299 and F4 cells was analyzed by real time quantification using the IncuCyte system. D) After 24 h pretreatment with indicated doses of ibuprofen, invasion ability of H1299 and F4 cells was analyzed by matrigel transwell system. Invaded cell number was normalized with cell viability and the relative invasion was normalized with the control cells. E) EFHD2-KD and the control H1299 cells and F) EFHD2-OE and the control A549 cells were pretreated with or without 600 μM ibuprofen for 24 h, and then indicated doses of cisplatin were added into culture media for another 24 h. Cell viability were determined by MTT assay. ★★ , <0.01.
Piroxicam, supplied by Taito corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/piroxicam/piroxicam/pm15504254-26-16-19
Average 90 stars, based on 1 article reviews
piroxicam - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
piroxicam jenapharm  (Jenapharm GmbH Co KG)
90
Jenapharm GmbH Co KG piroxicam jenapharm
Ibuprofen suppresses EFHD2 and sensitizes lung cancer cells to cisplatin. A) NSAIDs, aspirin 500 μM, diclofenac 40 μM, ibuprofen 600 μM, ketorolac 10 μM, mefenamic acid 2 μM, <t>piroxicam</t> 10 μM, and sulindac 20 μM, were used to treat both H1299 and F4 cells for 24 h. EFHD2 levels were determined by Western blot assay. B) H1299 and F4 cells were treated with indicated dose of ibuprofen. The relative EFHD2 levels in each sample were normalized to the control cell. β-actin, loading control. C) After 24 h pretreatment with indicated doses of ibuprofen, migration ability of H1299 and F4 cells was analyzed by real time quantification using the IncuCyte system. D) After 24 h pretreatment with indicated doses of ibuprofen, invasion ability of H1299 and F4 cells was analyzed by matrigel transwell system. Invaded cell number was normalized with cell viability and the relative invasion was normalized with the control cells. E) EFHD2-KD and the control H1299 cells and F) EFHD2-OE and the control A549 cells were pretreated with or without 600 μM ibuprofen for 24 h, and then indicated doses of cisplatin were added into culture media for another 24 h. Cell viability were determined by MTT assay. ★★ , <0.01.
Piroxicam Jenapharm, supplied by Jenapharm GmbH Co KG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/piroxicam/piroxicam/10__3390_slash_scipharm86020021-143-1-4
Average 90 stars, based on 1 article reviews
piroxicam jenapharm - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
piroxicam  (Neuropharm Ltd)
90
Neuropharm Ltd piroxicam
Ibuprofen suppresses EFHD2 and sensitizes lung cancer cells to cisplatin. A) NSAIDs, aspirin 500 μM, diclofenac 40 μM, ibuprofen 600 μM, ketorolac 10 μM, mefenamic acid 2 μM, <t>piroxicam</t> 10 μM, and sulindac 20 μM, were used to treat both H1299 and F4 cells for 24 h. EFHD2 levels were determined by Western blot assay. B) H1299 and F4 cells were treated with indicated dose of ibuprofen. The relative EFHD2 levels in each sample were normalized to the control cell. β-actin, loading control. C) After 24 h pretreatment with indicated doses of ibuprofen, migration ability of H1299 and F4 cells was analyzed by real time quantification using the IncuCyte system. D) After 24 h pretreatment with indicated doses of ibuprofen, invasion ability of H1299 and F4 cells was analyzed by matrigel transwell system. Invaded cell number was normalized with cell viability and the relative invasion was normalized with the control cells. E) EFHD2-KD and the control H1299 cells and F) EFHD2-OE and the control A549 cells were pretreated with or without 600 μM ibuprofen for 24 h, and then indicated doses of cisplatin were added into culture media for another 24 h. Cell viability were determined by MTT assay. ★★ , <0.01.
Piroxicam, supplied by Neuropharm Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/piroxicam/piroxicam/pmc06681387__biomolecules___09___00269___s001-174-88-117
Average 90 stars, based on 1 article reviews
piroxicam - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
piroxicam pirocam  (Spirig Pharma AG)
90
Spirig Pharma AG piroxicam pirocam
Ibuprofen suppresses EFHD2 and sensitizes lung cancer cells to cisplatin. A) NSAIDs, aspirin 500 μM, diclofenac 40 μM, ibuprofen 600 μM, ketorolac 10 μM, mefenamic acid 2 μM, <t>piroxicam</t> 10 μM, and sulindac 20 μM, were used to treat both H1299 and F4 cells for 24 h. EFHD2 levels were determined by Western blot assay. B) H1299 and F4 cells were treated with indicated dose of ibuprofen. The relative EFHD2 levels in each sample were normalized to the control cell. β-actin, loading control. C) After 24 h pretreatment with indicated doses of ibuprofen, migration ability of H1299 and F4 cells was analyzed by real time quantification using the IncuCyte system. D) After 24 h pretreatment with indicated doses of ibuprofen, invasion ability of H1299 and F4 cells was analyzed by matrigel transwell system. Invaded cell number was normalized with cell viability and the relative invasion was normalized with the control cells. E) EFHD2-KD and the control H1299 cells and F) EFHD2-OE and the control A549 cells were pretreated with or without 600 μM ibuprofen for 24 h, and then indicated doses of cisplatin were added into culture media for another 24 h. Cell viability were determined by MTT assay. ★★ , <0.01.
Piroxicam Pirocam, supplied by Spirig Pharma AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/piroxicam/piroxicam+pirocam/10__1158_slash_1078___0432__ccr___05___0490-128-6-8
Average 90 stars, based on 1 article reviews
piroxicam pirocam - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
piroxicam  (SEDICO Pharmaceuticals)
90
SEDICO Pharmaceuticals piroxicam
Ibuprofen suppresses EFHD2 and sensitizes lung cancer cells to cisplatin. A) NSAIDs, aspirin 500 μM, diclofenac 40 μM, ibuprofen 600 μM, ketorolac 10 μM, mefenamic acid 2 μM, <t>piroxicam</t> 10 μM, and sulindac 20 μM, were used to treat both H1299 and F4 cells for 24 h. EFHD2 levels were determined by Western blot assay. B) H1299 and F4 cells were treated with indicated dose of ibuprofen. The relative EFHD2 levels in each sample were normalized to the control cell. β-actin, loading control. C) After 24 h pretreatment with indicated doses of ibuprofen, migration ability of H1299 and F4 cells was analyzed by real time quantification using the IncuCyte system. D) After 24 h pretreatment with indicated doses of ibuprofen, invasion ability of H1299 and F4 cells was analyzed by matrigel transwell system. Invaded cell number was normalized with cell viability and the relative invasion was normalized with the control cells. E) EFHD2-KD and the control H1299 cells and F) EFHD2-OE and the control A549 cells were pretreated with or without 600 μM ibuprofen for 24 h, and then indicated doses of cisplatin were added into culture media for another 24 h. Cell viability were determined by MTT assay. ★★ , <0.01.
Piroxicam, supplied by SEDICO Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/piroxicam/piroxicam/10__21608_slash_bfsa__2010__147018-43-0-4
Average 90 stars, based on 1 article reviews
piroxicam - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
piroxicam  (Toyama Chemical Co)
90
Toyama Chemical Co piroxicam
Ibuprofen suppresses EFHD2 and sensitizes lung cancer cells to cisplatin. A) NSAIDs, aspirin 500 μM, diclofenac 40 μM, ibuprofen 600 μM, ketorolac 10 μM, mefenamic acid 2 μM, <t>piroxicam</t> 10 μM, and sulindac 20 μM, were used to treat both H1299 and F4 cells for 24 h. EFHD2 levels were determined by Western blot assay. B) H1299 and F4 cells were treated with indicated dose of ibuprofen. The relative EFHD2 levels in each sample were normalized to the control cell. β-actin, loading control. C) After 24 h pretreatment with indicated doses of ibuprofen, migration ability of H1299 and F4 cells was analyzed by real time quantification using the IncuCyte system. D) After 24 h pretreatment with indicated doses of ibuprofen, invasion ability of H1299 and F4 cells was analyzed by matrigel transwell system. Invaded cell number was normalized with cell viability and the relative invasion was normalized with the control cells. E) EFHD2-KD and the control H1299 cells and F) EFHD2-OE and the control A549 cells were pretreated with or without 600 μM ibuprofen for 24 h, and then indicated doses of cisplatin were added into culture media for another 24 h. Cell viability were determined by MTT assay. ★★ , <0.01.
Piroxicam, supplied by Toyama Chemical Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/piroxicam/piroxicam/pmc04668819-148-12-14
Average 90 stars, based on 1 article reviews
piroxicam - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
piroxicam  (Cincinnati Lab Supply Inc)
90
Cincinnati Lab Supply Inc piroxicam
Ibuprofen suppresses EFHD2 and sensitizes lung cancer cells to cisplatin. A) NSAIDs, aspirin 500 μM, diclofenac 40 μM, ibuprofen 600 μM, ketorolac 10 μM, mefenamic acid 2 μM, <t>piroxicam</t> 10 μM, and sulindac 20 μM, were used to treat both H1299 and F4 cells for 24 h. EFHD2 levels were determined by Western blot assay. B) H1299 and F4 cells were treated with indicated dose of ibuprofen. The relative EFHD2 levels in each sample were normalized to the control cell. β-actin, loading control. C) After 24 h pretreatment with indicated doses of ibuprofen, migration ability of H1299 and F4 cells was analyzed by real time quantification using the IncuCyte system. D) After 24 h pretreatment with indicated doses of ibuprofen, invasion ability of H1299 and F4 cells was analyzed by matrigel transwell system. Invaded cell number was normalized with cell viability and the relative invasion was normalized with the control cells. E) EFHD2-KD and the control H1299 cells and F) EFHD2-OE and the control A549 cells were pretreated with or without 600 μM ibuprofen for 24 h, and then indicated doses of cisplatin were added into culture media for another 24 h. Cell viability were determined by MTT assay. ★★ , <0.01.
Piroxicam, supplied by Cincinnati Lab Supply Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/piroxicam/piroxicam/pmc03057426-75-34-48
Average 90 stars, based on 1 article reviews
piroxicam - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
piroxicam biomol research  (Biomol GmbH)
90
Biomol GmbH piroxicam biomol research
Ibuprofen suppresses EFHD2 and sensitizes lung cancer cells to cisplatin. A) NSAIDs, aspirin 500 μM, diclofenac 40 μM, ibuprofen 600 μM, ketorolac 10 μM, mefenamic acid 2 μM, <t>piroxicam</t> 10 μM, and sulindac 20 μM, were used to treat both H1299 and F4 cells for 24 h. EFHD2 levels were determined by Western blot assay. B) H1299 and F4 cells were treated with indicated dose of ibuprofen. The relative EFHD2 levels in each sample were normalized to the control cell. β-actin, loading control. C) After 24 h pretreatment with indicated doses of ibuprofen, migration ability of H1299 and F4 cells was analyzed by real time quantification using the IncuCyte system. D) After 24 h pretreatment with indicated doses of ibuprofen, invasion ability of H1299 and F4 cells was analyzed by matrigel transwell system. Invaded cell number was normalized with cell viability and the relative invasion was normalized with the control cells. E) EFHD2-KD and the control H1299 cells and F) EFHD2-OE and the control A549 cells were pretreated with or without 600 μM ibuprofen for 24 h, and then indicated doses of cisplatin were added into culture media for another 24 h. Cell viability were determined by MTT assay. ★★ , <0.01.
Piroxicam Biomol Research, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/piroxicam/piroxicam/10__1515_slash_acve___2017___0039-67-4-6
Average 90 stars, based on 1 article reviews
piroxicam biomol research - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Ibuprofen suppresses EFHD2 and sensitizes lung cancer cells to cisplatin. A) NSAIDs, aspirin 500 μM, diclofenac 40 μM, ibuprofen 600 μM, ketorolac 10 μM, mefenamic acid 2 μM, piroxicam 10 μM, and sulindac 20 μM, were used to treat both H1299 and F4 cells for 24 h. EFHD2 levels were determined by Western blot assay. B) H1299 and F4 cells were treated with indicated dose of ibuprofen. The relative EFHD2 levels in each sample were normalized to the control cell. β-actin, loading control. C) After 24 h pretreatment with indicated doses of ibuprofen, migration ability of H1299 and F4 cells was analyzed by real time quantification using the IncuCyte system. D) After 24 h pretreatment with indicated doses of ibuprofen, invasion ability of H1299 and F4 cells was analyzed by matrigel transwell system. Invaded cell number was normalized with cell viability and the relative invasion was normalized with the control cells. E) EFHD2-KD and the control H1299 cells and F) EFHD2-OE and the control A549 cells were pretreated with or without 600 μM ibuprofen for 24 h, and then indicated doses of cisplatin were added into culture media for another 24 h. Cell viability were determined by MTT assay. ★★ , <0.01.

Journal: Redox Biology

Article Title: EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis

doi: 10.1016/j.redox.2020.101571

Figure Lengend Snippet: Ibuprofen suppresses EFHD2 and sensitizes lung cancer cells to cisplatin. A) NSAIDs, aspirin 500 μM, diclofenac 40 μM, ibuprofen 600 μM, ketorolac 10 μM, mefenamic acid 2 μM, piroxicam 10 μM, and sulindac 20 μM, were used to treat both H1299 and F4 cells for 24 h. EFHD2 levels were determined by Western blot assay. B) H1299 and F4 cells were treated with indicated dose of ibuprofen. The relative EFHD2 levels in each sample were normalized to the control cell. β-actin, loading control. C) After 24 h pretreatment with indicated doses of ibuprofen, migration ability of H1299 and F4 cells was analyzed by real time quantification using the IncuCyte system. D) After 24 h pretreatment with indicated doses of ibuprofen, invasion ability of H1299 and F4 cells was analyzed by matrigel transwell system. Invaded cell number was normalized with cell viability and the relative invasion was normalized with the control cells. E) EFHD2-KD and the control H1299 cells and F) EFHD2-OE and the control A549 cells were pretreated with or without 600 μM ibuprofen for 24 h, and then indicated doses of cisplatin were added into culture media for another 24 h. Cell viability were determined by MTT assay. ★★ , <0.01.

Article Snippet: I4883) were purchased from the Sigma-Aldrich; bafilomycin A1 (Baf-A1; Cat.No. sc-201550), aspirin (Cat.No. sc-202471), diclofenac (Cat.No. sc-357332), ketorolac (Cat.No. sc-205360), mefenamic acid (Cat.No. sc-205380), piroxicam (Cat.No. sc-200576), sulindac (Cat.No. sc-202823), and MG132 (Cat.No. sc-351846) were purchased from the Santa Cruz Biotechnology; flurbiprofen (Cat.No.

Techniques: Western Blot, Control, Migration, MTT Assay